MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the quarter ending 2025-09-30.

Cash Flow Overview

Free Cash flow
-$44,543K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net loss
-167,303 -
Depreciation and amortization
745 1,120
Share-based compensation expense
3,709 5,599
Net periodic pension benefit gain for the qualified pension plan
-18 -9
Other non-cash items
-283 1,211
Other receivables
612 566
Operating lease right-of-use assets
0 0
Prepaid expenses
-274 3,570
Other non-current assets
-1,110 1,697
Trade and other payables
8,203 8,087
Operating lease liabilities
-401 -444
Accrued expenses and other current liabilities
12,856 -3,368
Net cash flow used in operating activities
-44,543 -92,670
Purchase of short-term marketable debt securities
0 206,207
Proceeds from maturities of short-term marketable debt securities
88,403 350,742
Purchase of property and equipment
0 35
Net cash flow provided by (used in) investing activities
88,403 144,500
Proceeds from options exercised under esop
-100
Proceeds from long-term debt, net of issuance costs
0 73,022
Issuance of class a ordinary shares, net of transaction costs
0 0
Stamp duty on capital injection from moonlake to moonlake ag
0 0
Proceeds from options exercised-Equity Incentive Plan
480 -
Proceeds from options exercised-Employee Stock Option Plan ESOP
100 -
Net cash flow provided by financing activities
480 73,122
Effect of movements in exchange rates on cash held
-285 1,303
Net change in cash and cash equivalents
44,055 126,255
Cash and cash equivalents at beginning of period
180,426 -
Cash and cash equivalents at end of period
350,736 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

MoonLake Immunotherapeutics (MLTX)

MoonLake Immunotherapeutics (MLTX)